Article
Pall and New Brunswick Collaborate on Single-Use Bioreactors
Author(s):
New Brunswick Scientific, an Eppendorf Company (Edison, NJ), and Pall Corporation (Port Washington, NY) have entered into a product development and marketing agreement to create and supply new disposable bioreactor systems.
New Brunswick Scientific, an Eppendorf Company (Edison, NJ), and Pall Corporation (Port Washington, NY) have entered into a product development and marketing agreement to create and supply new disposable bioreactor systems.
The joint effort will build on the capabilities of Pall's Allegro single-use biocontainer platform and New Brunswick's CelliGen bioprocess controller to better serve upstream applications ranging from the process development laboratory to the full-scale cGMP production suite.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
